WHO honours HMC's Tobacco Control Centre with 2025 World No Tobacco Day Award
Doha
The World Health Organization (WHO) has recognised Hamad Medical Corporation's (HMC) Tobacco Control Centre with the 2025 World No Tobacco Day Award. The award recognises the Centre's significant efforts in reducing tobacco use and helping the public in Qatar and the Eastern Mediterranean region to quit all forms of tobacco use.
HMC's Tobacco Control Centre, which has been a WHO Collaborating Centre since 2017, was selected as one of the award recipients in the Eastern Mediterranean region. This marks the second time the Centre has received the award, having first been honoured in 2021. The award was presented by Dr. Rayana Bou Haka, WHO representative in Qatar, in the presence of Dr. Ahmed Al Mohammed, HMC's deputy chief medical officer for medical services and chairman of the Department of Medicine.
Dr Ahmad Mohamed Al Mulla, director of HMC's Tobacco Control Centre, expressed his pride in the Centre receiving the award for the second time. He praised the dedication of the Centre's team and the achievements in tobacco control in Qatar and the Eastern Mediterranean region. He said: 'HMC's Tobacco Control Centre has played a pioneering role in helping members of the public quit all forms of tobacco. This recognition by WHO reflects the positive outcomes of the hard work carried out by the Centre's team and its impact on many tobacco users in our community.'
Dr. Rayana Bou Haka also commended the Centre's local and regional activities and said the award was well-deserved. She thanked the Centre's staff for their continued efforts in tobacco control in Qatar and the region and emphasised the importance of continued collaboration between the Centre and WHO, given the significant value of its tobacco control programs.
The Tobacco Control Centre organizes educational and awareness initiatives targeting school and university students, as well as employees in ministries and public institutions. The Centre also delivers training programs for healthcare professionals and community organizations in Qatar and across the Eastern Mediterranean. In addition, it provides smoking cessation services and conducts research in the field of tobacco cessation.
Dr Ahmad Al Mulla extended his gratitude to HMC leadership and the WHO Eastern Mediterranean Regional Office, represented by Dr Fatimah El Awa, WHO's Regional Advisor for the Tobacco Free Initiative, as well as the WHO Tobacco Free Initiative Office in Geneva, for their continuous support of the Centre's programs.
He noted that this support contributes to the positive impact of the Centre's tobacco control activities at all levels in Qatar and the wider region.
WHO annually recognizes individuals and institutions from each of its six regions on the occasion of World No Tobacco Day for their outstanding contributions to tobacco control.
The recognition includes honorary awards, special certificates of appreciation from the WHO Director-General, and awards specifically related to World No Tobacco Day.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
19 hours ago
- Qatar Tribune
HMC launches Oncology Rehabilitation Framework
Tribune News Network Doha In an advancement for cancer survivorship and holistic care in the country, Hamad Medical Corporation (HMC) has launched the first of its kind Oncology Rehabilitation Framework. With rising cancer prevalence and growing survivorship rates in Qatar, this national initiative is the result of collaborative leadership between the Qatar Rehabilitation Institute (QRI) and the National Center for Cancer Care and Research (NCCCR). The comprehensive, nationally driven oncology rehabilitation framework addresses the full spectrum of physical, psychological, and social challenges patients face throughout their cancer journey. Grounded in international evidence and best practices, the framework reflects WHO Rehabilitation Interventions carefully adapted to Qatar's healthcare landscape and cultural context. Dr Hanadi Al Hamad, Deputy Chief of Rehabilitation, Geriatrics, Long Term and Home Care Services, and Lead of Rehabilitation Therapy Services at HMC emphasised the national importance of the initiative, stating: 'This launch marks a turning point for cancer care in Qatar. We are shifting the paradigm—moving beyond survival to ensuring that patients live with dignity, function, and independence. In line with the National Health Strategy 2024 - 2030, rehabilitation is now recognized as an essential part of the patient journey.' Dr Mohamed Salem Al Hassan, CEO and medical director of NCCCR, added: 'We are entering a new era of cancer services in Qatar—one that sees survivorship as a critical phase requiring multidisciplinary support. This framework establishes a structured, accessible, and compassionate model of care that supports every patient, each step of the way.' The National Oncology Rehabilitation Framework represents a step forward in advancing HMC's strategic vision for integrated, high-quality care. It is fully aligned with the priorities National Health Strategy 2024 –2030 and contributes directly to the goals of the Qatar National Vision 2030 by enhancing population health, building system sustainability, and empowering local capabilities. Globally, it reflects the principles of the WHO Rehabilitation 2030 Call for Action, promoting equitable, person-centered, and function-focused rehabilitation services as a core part of universal health coverage. With this launch, Qatar affirms its commitment to ensuring that people affected by cancer are supported not only to survive—but to live fully, regain independence, and enjoy a meaningful quality of life beyond their diagnosis. The National Oncology Rehabilitation Framework signals a future where recovery is defined not just by remission, but by restoring physical function, emotional well-being, and social reintegration—ensuring that every patient has the opportunity to thrive, not just survive.
Qatar Tribune
19 hours ago
- Qatar Tribune
WHO sounds alarm bells: Loneliness makes many people sick
One in six people worldwide is affected by loneliness, which, along with social isolation, can lead to physical illness, contributing to 871,000 deaths worldwide annually, a World Health Organization (WHO) commission has said. Loneliness increases the risk of strokes, heart attacks, diabetes, depression, anxiety and suicide, the WHO said. Lonely teenagers are 22% more likely to achieve lower grades than their peers, while lonely adults face greater challenges in finding or keeping a job. The impact is not only individual but also societal, with billions in costs to healthcare systems and losses in employment. The role of mobile phones and living alone The commission's co-chair, Vivek Murthy, defines loneliness as 'a painful, subjective feeling that many of us experience when the relationships that we need do not match the relationships that we have. And social isolation, by contrast, is an objective state of having few relationships or interactions.' One in three older people and one in four adolescents are estimated to be socially isolated, according to the report. Causes include illness, poor education, low income, a lack of opportunities for social interaction, living alone and the use of digital technologies. Murthy noted that humans have communicated for millennia not only through words but also through facial expressions, body language, tone of voice and silence. These forms of communication are lost when people rely solely on mobile phones and social media. Sweden's strategy against loneliness The WHO highlighted Sweden as a positive example. The country has implemented a national strategy against loneliness, as reported by Swedish Social Minister Jakob Forssmed. Sweden recognizes that loneliness is not just an individual problem but one that affects society as a whole. Efforts are being made to foster social connections in places like shops, restaurants, neighbourhoods and clubs. Soon, all children and teenagers in Sweden will receive prepaid cards that can only be used to book group leisure activities. Sweden plans to ban mobile phones in public schools, Forssmed said. Studies have shown that this increases social interaction and reduces cyberbullying. Children and teenagers sleep better and find it easier to put their phones aside during their free time. Forssmed added that children are often frustrated when their parents are constantly distracted by their phones. Finding phone-free times While digital technologies have their benefits, such as enabling video calls that were previously impossible, the commission emphasized the importance of creating spaces in life where people can interact face-to-face without technological distractions. Murthy said 'having places and spaces in our life where we can interact face to face with other people without the distraction of technology is very important.' (DPA)
Qatar Tribune
2 days ago
- Qatar Tribune
HMC highlights advanced diagnostics, and treatment on World Allergy Week
Tribune News Network Doha Hamad Medical Corporation's (HMC) Allergy and Clinical Immunology Division is marking World Allergy Week 2025 by highlighting the range of specialised services it provides to deliver comprehensive, patient-centred care for individuals affected by allergic and immunological conditions. The division specialises in diagnosing and treating conditions, lik asthma, allergic rhinitis, chronic urticaria, atopic dermatitis, food allergies, drug allergies, insect venom allergy, anaphylaxis, and eosinophilic esophagitis. It serves adults and children by combining expert clinical knowledge with advanced diagnostic technologies to improve patients' quality of life. 'This World Allergy Week, we want to emphasise that allergies are serious medical conditions that can impact the quality of life, but with proper diagnosis and treatment, they are highly manageable,' said Dr. Asaad Imameldin, specialist Allergy/Immunology and Internal Medicine. 'Accurate diagnosis is key to effective allergy management, and our approach combines advanced diagnostic testing with personalised treatment plans, ensuring that every patient receives care tailored to their specific allergies,' he added. The division offers a range of cutting-edge diagnostic methods, including skin prick testing, intradermal testing, patch testing, serum-specific IgE blood tests, oral food challenges, drug provocation testing, and spirometry for lung function assessment. Treatment plans are personalised to each patient's specific allergies and lifestyle, with options ranging from medication management and allergen avoidance counselling to immunotherapy and biologic therapies for severe conditions. Emergency action plans are developed for patients at risk of severe reactions, including the use of epinephrine auto-injectors and usage training. Patient education remains a cornerstone of the division's approach, with emphasis on teaching patients and families about allergy prevention and management through awareness programs, informational materials and personalized counselling. There are also educational programmes to guide patients on how to recognise symptoms early, avoid triggers and manage emergencies. Patients experiencing allergic condition symptoms or severe reactions are encouraged to seek consultation at HMC's Allergy and Clinical Immunology Division for early diagnosis and treatment that can significantly improve quality of life.
